Angiotensin-Converting Enzyme Inhibitor-Induced Non-allergic Perioral Angioedema: A Case-Based Scoping Review
Issued Date
2023-01-01
Resource Type
ISSN
20056443
eISSN
20926715
Scopus ID
2-s2.0-85148235850
Journal Title
Korean Journal of Family Medicine
Volume
44
Issue
1
Start Page
2
End Page
10
Rights Holder(s)
SCOPUS
Bibliographic Citation
Korean Journal of Family Medicine Vol.44 No.1 (2023) , 2-10
Suggested Citation
Pitak-Arnnop P., Subbalekha K., Muangchan C., Auychai P., Sirintawat N., Meningaud J.P., Neff A. Angiotensin-Converting Enzyme Inhibitor-Induced Non-allergic Perioral Angioedema: A Case-Based Scoping Review. Korean Journal of Family Medicine Vol.44 No.1 (2023) , 2-10. 10. doi:10.4082/kjfm.21.0095 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/82577
Title
Angiotensin-Converting Enzyme Inhibitor-Induced Non-allergic Perioral Angioedema: A Case-Based Scoping Review
Other Contributor(s)
Abstract
Patients with angiotensin-converting enzyme inhibitor (ACEI)-induced angioedema (ACEIIA) may visit family physicians. The aim of this article was to describe a case of delayed-onset ACEIIA and to present a concise scoping review. Using a case report and a scoping review study design, we report a case of ACEIIA, with clinically confirmed diagnosis. The symptoms resolved after replacing the offending ACEI with another antihypertensive agent. After excluding other causes of perioral swelling and discontinuation of ACEI, the patient was symptom-free within a few days thereafter. Based on this case presentation, we performed a meta-narrative scoping review including up-todate diagnosis and management of ACEIIA, based on published data in English, French, and German from inception to April 1, 2021. Patients with angioedema of unknown origin should be cautiously examined to rule out oral diseases, including allergy to dental materials and drug-induced angioedema. Clinicopathological aspects and current treatment guidelines for ACEI-associated angioedema are also presented